FDA and Healthcare

Tony Burba is an associate in the Washington, DC office of Arnold & Porter, LLP. Mr. Burba is a member of the firm's White Collar Criminal Defense group, and advises providers and suppliers in the healthcare industry on a wide range of fraud and abuse issues. His practice involves both trial advocacy in criminal and civil actions brought by the government, as well as internal investigations and self-referrals to various regulatory authorities including the Centers for Medicare and Medicaid Services and the Office of Inspector General of the US Department of Health and Human Services. Mr. Burba is a former prosecutor for the Fraud Section of the Criminal Division for the US Department of Justice. While with the Department of Justice, Mr. Burba worked on the Medicare Fraud Strike Forces in Miami, Florida and Houston, Texas, where he investigated, charged, and prosecuted various healthcare providers and suppliers for Medicare fraud.

Mr. Burba graduated in the top 10 percent of his class from the University of Kentucky College of Law, where he was a member of the Journal of Natural Resources and Environmental Law as well as the Moot Court Board.

FDA and Healthcare Representative Matters

• Assisted a regional hospital management company in the internal investigation and self-reporting of potential Stark violations at one of its facilities. The disclosure was made to HHS-OIG pursuant to the requirements of an existing Corporate Integrity Agreement.
• Represented a regional hospital, on behalf of its parent company, in a government investigation, which resulted in a civil settlement and the negotiation of a Corporate Integrity Agreement.
• Performed an internal investigation of potential Anti-kickback Statute violations for a large international medical device manufacturer.
• Represented large national home health provider in responding to a subpoena from the Finance Committee of the United States Senate.
• Second-chaired the criminal trial of a Maryland cardiologist charged with Medicare Fraud in connection with allegations concerning the placement of alleged medically unnecessary cardiac stenting.